AVVA Pharmaceuticals Ltd is a research-based pharmaceutical company, an industry leader in the development and production of innovative medicines that address common medical needs, building on its knowledge derived from the research of the human microbiome.
Our portfolio includes a number of inventions that will replace current standards in the field of infectious and metabolic diseases.
Our mission is to develop and produce innovative medical products aimed at improving treatment safety and chronic disease prevention.
Our vision is to simplify medical care by improving the efficacy and safety profile of commonly used medication, transforming it into medicines that would not alter the current therapeutic approach but enhance it.
A strategic marketing agreement was concluded with OJSC Farmstandart on joint promotion of the medical products such as Micrazim, Lactofiltrum, Filtrum, Ursoliv, and Dinolac in the Russian Federation market.
Ursoliv and Ecoantibiotics were launched in the Russian Federation and CIS.
The pharmaceutical company AVVA RUS was founded. Both AVVA RUS and the Swiss company AVVA Pharmaceuticals AG are members of AVVA Group. The company AVVA Ukraine and the representative office in the Republic of Uzbekistan AVVA Uzbekistan were established.
Beginning of cooperation with AVVA Pharmaceuticals AG on development and registration of Ecoantibiotics. An R&D laboratory for new medical products was established.
Founding of the Leksir pharmaceutical group comprising of: Leksir – engineering and marketing company which is also the group managing company (located in Moscow); and Leksir Ukraine – the representative office.
Building and launch of hydrolyzed lignin manufacturing facility and development of medical products based on it.